BRIEF published on 10/02/2024 at 14:27, 1 month 19 days ago The Vanguard Group, Inc. Discloses Position in Britvic Plc Britvic Plc Rule 8.3 Takeover Code Vanguard Group Stock Disclosure
PRESS RELEASE published on 10/02/2024 at 14:22, 1 month 19 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.44% stake in Britvic plc as of 01/10/2024. No other party disclosures noted. Shawn Acker contact for Form 8.3 Form 8.3 Britvic Plc Vanguard Group Stake Disclosure Shawn Acker
BRIEF published on 10/01/2024 at 15:34, 1 month 20 days ago The Vanguard Group, Inc. Discloses 5.43% Stake in Britvic plc Securities Takeover Code Stake Disclosure Vanguard Britvic
PRESS RELEASE published on 10/01/2024 at 15:29, 1 month 20 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses a 5.43% stake in Britvic plc as of 30 September 2024. Purchase of 49,168 securities at 12.75 GBP per unit Britvic Plc The Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase
BRIEF published on 10/01/2024 at 11:00, 1 month 20 days ago Societe Generale Reaches 5.045900% Stake in Britvic PLC Acquisition Voting Rights Société Générale Stock Market Britvic
BRIEF published on 10/01/2024 at 10:56, 1 month 20 days ago Morgan Stanley Reduces Voting Rights in Britvic Plc Below 5% Voting Rights Britvic Plc Shareholding Morgan Stanley Trading Book Exemption
PRESS RELEASE published on 10/01/2024 at 10:55, 1 month 20 days ago Holding(s) in Company Societe Generale discloses 5.05% voting rights in Britvic plc - BVIC. Notification of major shareholding reached on 26-Sep-2024, notified on 27-Sep-2024 in London, UK Société Générale Britvic Plc BVIC Notification Major Shareholding
BRIEF published on 10/01/2024 at 10:54, 1 month 20 days ago Morgan Stanley Increases Stake in Britvic Plc Voting Rights Investment Morgan Stanley Britvic Equity Swap
PRESS RELEASE published on 10/01/2024 at 10:51, 1 month 20 days ago Holding(s) in Company Morgan Stanley notifies holding below 5% in Britvic plc (BVIC). Trading book exemption applied to remaining 4.97% holding as of 26.09.2024 Britvic Plc BVIC Morgan Stanley Holding Notification Trading Book Exemption
PRESS RELEASE published on 10/01/2024 at 10:49, 1 month 20 days ago Holding(s) in Company Morgan Stanley discloses acquisition of voting rights in Britvic plc (BVIC) on 20-Sep-2024 Acquisition Voting Rights Britvic Plc BVIC Morgan Stanley
Published on 11/22/2024 at 00:00, 5 hours 59 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 54 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours 9 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 44 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 49 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 10 hours 58 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 23 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:51, 12 hours 7 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 12 hours 7 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 23 hours 1 minute ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 10 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 12 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 12 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 22 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
